BioCentury
ARTICLE | Financial News

UCB spinout Syndesi raises €17M series A

February 2, 2018 8:14 PM UTC

UCB S.A. (Euronext:UCB) spinout Syndesi Therapeutics S.A. (Louvain-la-Neuve, Belgium) launched with a €17 million ($21.1 million) series A round led by Novo Seeds and Fountain Healthcare with participation from Johnson and Johnson innovation, V-BIO ventures, the Walloon Investment Fund (SRIW) and VIVES Louvain Technology fund. ...

BCIQ Company Profiles

Syndesi Therapeutics S.A.